As FDA misses deadline on electric shock ban, disability advocates speak out
The FDA has missed a self-imposed deadline to ban the use of electrical shock devices in people with intellectual disabilities.
Read full article →Healthcare Policy
Latest Healthcare Policy news from across the web.
STAT+: Medicare’s mum on GLP-1s, and Massachusetts sues United
We've been asking Medicare for weeks about the cost of giving seniors $50 obesity drugs.
Read full article →STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more
Detailed study data for a pancreatic cancer treatment from Revolution Medicines confirmed it increased overall survival, from 13.2 months to 6.7 months
Read full article →Opinion: What should hospitals do when patients demand unvaccinated donor blood?
“You have to understand a person's belief if you want to address it,” Deva Sharma says on the “First Opinion Podcast” about requests for unvaccinated donor blood.
Read full article →STAT+: A turning point for pancreatic cancer patients
Eli Lilly announces two China deals, Akeso's lung cancer bispecific payoff, and more biotech news from The Readout
Read full article →CDC says containing the spread of Ebola is top priority
The Trump administration disregards infectious disease playbook, CEPI offers vaccine funding, and other health news from Morning Rounds
Read full article →STAT+: Servier to buy Edgewise Therapeutics’ muscular dystrophy drug
The French pharma firm Servier is buying an experimental muscular dystrophy drug from Edgewise Therapeutics for $1.55 billion upfront.
Read full article →A cancer vaccine made just for you. mRNA is back and it's fighting melanoma
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.
Read full article →STAT+: No Surprises Act arbitration rule could worsen flood of provider disputes
The arbitration process has protected patients but generated financial windfalls for some clinicians.
Read full article →The hidden history of BPC-157, a favorite MAHA peptide
A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using peptides.
Read full article →STAT+: Medicare still won’t say how much covering obesity drugs will cost
Older adults on Medicare can get Wegovy and Zepbound for $50 a month, starting in July. But the agency still is not sharing how much this will cost taxpayers.
Read full article →STAT+: Executives reveal tech initiatives at Summa Health, eight months after General Catalyst acquisition
Two years after General Catalyst said it was buying Ohio safety-net hospital Summa Health, executives shed light on how the “transformation” is going.
Read full article →